ERA-EDTA 2011 Congress Conference Review - Reviewed by A/Prof David Mudge

In this review:

Rituximab no worse than standard therapy in ANCA+ vasculitis
HDF vs. HD: two studies
Bardoxolone improves renal function in type 2 diabetics with CKD
No significant slowing of renal disease progression with LDL lowering

Please login below to download this issue (PDF)